Results 101 to 110 of about 4,760,541 (315)

Conference Proceedings: Select Abstracts Presented at the 2025 Advocate Aurora Scientific Day

Journal of Patient-Centered Research and Reviews
This abstract supplement includes findings presented through oral or poster presentations at the 51st annual Scientific Day event held on May 21, 2025.
Advocate Aurora Scientific Day
doaj   +1 more source

Geographic and health system correlates of interprofessional oral health practice

Family Medicine and Community Health, 2018
Objective: This study explores geographic, system, and organizational constructs that predict medical care teams’ willingness to administer fluoride varnish and conduct oral health risk assessments.
Sean G. Boynes, Abigail Lauer, Amy Martin   +2 more
doaj   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

FEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

New Zealand regions, 1986-2001: Population dynamics

, 2005
New Zealand regions have markedly different population dynamics. Population change in a region is driven by three different factors: fertility, mortality and migration.
Lindop, J., Pool, Ian, Baxendine, Sandra, Cochrane, William   +3 more
core  

Population Council Strategic Plan 2023–2030

, 2022
For 70 years, the Population Council has transformed global thinking on critical health and development issues through our social science, public health, and biomedical research.
Population Council
core  

Increasing access to care through digital health for the Medicaid population: a novel community case study

Frontiers in Digital Health
There is a growing consensus among healthcare professionals and policymakers that the way healthcare has historically been provided within the United States is insufficient to meet the needs of the population. The incidence and prevalence of many chronic
Melinda Cooling, Melinda Cooling, Colleen J. Klein, Colleen J. Klein, Matthew D. Dalstrom, Roopa Foulger, Jennifer Junis, Jonathan A. Handler   +7 more
doaj   +1 more source

From mice to humans—divergent strategies for intestinal homeostasis and regeneration

FEBS Letters, EarlyView.
Recent advances such as organoid genome editing, xenotransplantation, imaging, and whole‐genome sequencing have enabled direct studies of human intestinal stem cells (ISCs). These studies reveal species‐specific features, including slower ISC proliferation, distinct injury responses, slower somatic mutation accumulation in humans, and an inverse ...
Keiko Ishikawa, Shinya Sugimoto, Toshiro Sato   +2 more
wiley   +1 more source

New Zealand regions, 1986-2001: Population structures

, 2005
The age structure of a region’s population affects many areas of social and economic development across all sectors, including employment, housing, welfare, health and education.
Lindop, J., Pool, Ian, Baxendine, Sandra, Cochrane, William   +3 more
core  

Vietnam Inequalities in Health, Nutrition and Population

, 2003
This paper focuses on the inequalities in health, nutrition, and population in Vietnam. It presents data on disaggregated health status and health services utilization that is organized by asset or wealth quintiles,
Ritu Chhabra, Elizabeth Lule, Lule, Elizabeth, Nandini Oomman, Chhabra, Ritu, Oomman, Nandini   +5 more
core   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source